These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6180597)

  • 1. Dextran-induced lowering of plasminogen proactivator and functionally active high molecular weight kininogen in the rat.
    Berstad J; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):342-9. PubMed ID: 6180597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of factor XII in rat plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Berstad J
    Acta Pharmacol Toxicol (Copenh); 1981 Jul; 49(1):43-51. PubMed ID: 6175175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of plasma kallikrein and a kallikrein-like plasminogen activator generated by acetone in rat plasma.
    Johansen HT; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1983 May; 52(5):371-80. PubMed ID: 6554030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran-induced lowering of prekallikrein proactivator and prekallikrein in rat plasma.
    Briseid G; Briseid K; Toverud EL; Kristoffersen J
    Acta Pharmacol Toxicol (Copenh); 1978 Feb; 42(2):93-102. PubMed ID: 580160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prekallikrein activator and kallikrein in acetone- and kaolin-activated rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):174-80. PubMed ID: 506739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma.
    Briseid K; Johansen R; Rustenberg L
    Adv Exp Med Biol; 1979; 120B():101-12. PubMed ID: 517228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of prekallikrein as plasminogen proactivator in plasma specimens from reactors to dextran or to contrast media.
    Briseid K; Johansen HT
    Int J Tissue React; 1984; 6(6):529-36. PubMed ID: 6085073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of factor XII in human plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Johansen HT
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):344-52. PubMed ID: 6685967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by low molecular weight dextran of the blood pressure fall and the lowering of plasminogen proactivator induced by clinical dextran in the rat.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):143-9. PubMed ID: 6189362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of factor XII in plasma from rats pretreated with tranexamic acid. Inhibition of a plasmin-induced loss of the functional activity of high molecular weight kininogen.
    Briseid K; Ryssdal AB
    Acta Pharmacol Toxicol (Copenh); 1980 Sep; 47(3):161-70. PubMed ID: 6449829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextran-induced anaphylactoid reaction in man: altered reactivity of high molecular weight kininogen.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):119-26. PubMed ID: 6159774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cofactor function of human high molecular weight kininogen induced by rat plasma kallikrein.
    Hoem NO; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1985 Jul; 57(1):47-52. PubMed ID: 3850711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of intravenous serotonin and dextran on the levels of factor XII, prekallikrein and plasminogen in rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):314-20. PubMed ID: 6154406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The initial phase of the dextran-induced anaphylactoid reaction in the rat: a comparison of inhibitors of the blood pressure fall.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1982 Aug; 51(2):141-6. PubMed ID: 6180599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of factor XII in acetone-treated human plasma: significance of the functional state of plasma kallikrein for the extent of activation.
    Hoem NO; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):144-50. PubMed ID: 3490738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of the third kininogen in high and low molecular weight kininogens-deficient Brown Norway Katholiek rat.
    Hayashi I; Ino T; Kato H; Iwanaga S; Nakano T; Oh-ishi S
    Thromb Res; 1984 Dec; 36(6):509-16. PubMed ID: 6570369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
    Johansen HT; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1984 Jul; 55(1):25-32. PubMed ID: 6431752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein.
    Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
    Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of T-kininogen in high and low molecular weight kininogens deficient rat (brown Norway Katholiek strain).
    Hayashi I; Oh-ishi S; Kato H; Enjyoji K; Iwanaga S; Nakano T
    Thromb Res; 1985 Aug; 39(3):313-21. PubMed ID: 3850646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.